Aromasin "Suicide Inhibition" May Distinguish Drug From Other Inhibitors
Executive Summary
Aromasin's labeled "suicide inhibition" mechanism of action could be used by Pharmacia & Upjohn to distinguish the new drug, approved Oct. 21, from nonsteroidal aromatase inhibitors in the treatment of breast cancer.